THERAPEUTIC AREAS:

> Neuroscience
> Metabolics
> Men's and Women's Health
> Cardiovascular
> Infectious Disease
> Oncology
> Pain and Inflammation
> Respiratory

METABOLICS & DIABETES

Type II Diabetes (GLP-1) Recruitment | Type II Diabetes (GLP-1) Retention
Type II Diabetes | Type I Diabetes (Inhaled Insulin) | Type II Diabetes

HCG’s work in metabolics is unmatched, covering a comprehensive range of protocol challenges including:

Type 2 Diabetes
• Stringent inclusionary/exclusionary OADs
• Drug naïve with HbA1c ≥7
• Insulin treatment, inhaled and injected
• Hypertension, hyperlipidemia, obesity and Peripheral Artery Disease (PAD)

Type 1 Diabetes
• Basal-bolus insulin
• Inhaled insulin
• Long-acting insulin

Obesity
• Type 2 diabetes as co-morbidity
• 80% retention of subjects over two years
• 5% weight loss within 12 weeks

Our programs have covered feasibility and site selection in addition to recruitment, retention and site support services. HCG has experience with over 700 investigative sites conducting diabetes studies worldwide. This has helped us build a “best recruitment practices” profile for diabetes. In the typical HCG site-supported program, 30%-50% of consented patients can be traced to HCG efforts.